증권 기록 · 과거 분기 (아카이브)
AKRO
Akero Therapeutics, Inc. · Healthcare · Biotechnology
18추적 보유자
0Δ 보유자
30.14M보유 주식 수
$1.43B보고 가치
+1신규 편입 포지션
−1청산
모멘텀 입력값 (비교 가능한 운용사): 보유자 폭 0.0% · 주식 흐름 -4.1% · 순 신규 포지션 0.0% — 산식
모든 소유권 수치: 추적 대상 13F 운용사 한정, 보통주 포지션, 보고 기간 Q3 2025
시계열 보유 현황
| 분기 | 보유자 | Δ | 주식 수 | 보고 가치 | 신규 | 청산 |
|---|---|---|---|---|---|---|
| Q3 2025 | 18 | 0 | 30.14M | $1.43B | +1 | −1 |
| Q2 2025 | 15 | -1 | 29.65M | $1.58B | — | −1 |
| Q1 2025 | 13 | +1 | 19.73M | $798.59M | +1 | — |
| Q4 2024 | 12 | +3 | 18.33M | $510.05M | +3 | — |
| Q3 2024 | 8 | 0 | 15.01M | $430.62M | +1 | −1 |
| Q2 2024 | 8 | — | 11.90M | $279.29M | — | — |
보유 현황 · Q3 2025
| # | 운용사 | 주식 수 | Δ 주식 수 | 가치 | 비중 | 보유 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (패시브) | 5.70M | -1.3% | $270.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (패시브) | 5.70M | -1.3% | $270.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (패시브) | 5.70M | -1.3% | $270.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (패시브) | 5.70M | -1.3% | $270.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (패시브) | 5.70M | -1.3% | $270.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (패시브) | 5.70M | -1.3% | $270.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (패시브) | 5.70M | -1.3% | $270.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (패시브) | 5.70M | -1.3% | $270.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (패시브) | 5.70M | -1.3% | $270.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (패시브) | 5.70M | -1.3% | $270.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (패시브) | 5.70M | -1.3% | $270.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (패시브) | 5.70M | -1.3% | $270.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | BlackRock ✦ (패시브) | 5.70M | -1.3% | $270.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | BlackRock ✦ (패시브) | 5.70M | -1.3% | $270.76M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (패시브) | 4.53M | -0.1% | $214.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (패시브) | 4.53M | -0.1% | $214.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | The Vanguard Group ✦ (패시브) | 4.53M | -0.1% | $214.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | The Vanguard Group ✦ (패시브) | 4.53M | -0.1% | $214.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | The Vanguard Group ✦ (패시브) | 4.53M | -0.1% | $214.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Wellington Management ✦ | 4.25M | +24.7% | $201.88M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | Wellington Management ✦ | 4.25M | +24.7% | $201.88M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Wellington Management ✦ | 4.25M | +24.7% | $201.88M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | Wellington Management ✦ | 4.25M | +24.7% | $201.88M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 24 | Wellington Management ✦ | 4.25M | +24.7% | $201.88M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | Wellington Management ✦ | 4.25M | +24.7% | $201.88M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 26 | Wellington Management ✦ | 4.25M | +24.7% | $201.88M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 27 | Wellington Management ✦ | 4.25M | +24.7% | $201.88M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 28 | T. Rowe Price ✦ | 3.81M | -15.5% | $180.89M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 29 | T. Rowe Price ✦ | 3.81M | -15.5% | $180.89M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 30 | State Street Global Advisors ✦ (패시브) | 3.41M | +24.4% | $162.11M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 31 | Geode Capital Management ✦ (패시브) | 1.79M | +3.7% | $84.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 32 | Geode Capital Management ✦ (패시브) | 1.79M | +3.7% | $84.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 33 | Point72 Asset Management ✦ | 1.66M | -38.6% | $78.98M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 34 | Marshall Wace ✦ | 1.22M | -14.2% | $57.79M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 35 | Marshall Wace ✦ | 1.22M | -14.2% | $57.79M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 36 | Marshall Wace ✦ | 1.22M | -14.2% | $57.79M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 37 | Fidelity (FMR) ✦ | 1.08M | +15.8% | $51.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 38 | Fidelity (FMR) ✦ | 1.08M | +15.8% | $51.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 39 | Fidelity (FMR) ✦ | 1.08M | +15.8% | $51.26M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 40 | Goldman Sachs Group ✦ | 855.77K | — | $40.63M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Goldman Sachs Group ✦ | 855.77K | — | $40.63M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Citadel Advisors ✦ | 685.84K | -41.4% | $32.56M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 43 | Citadel Advisors ✦ | 685.84K | -41.4% | $32.56M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 577.94K | — | $27.44M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | JPMorgan Chase ✦ | 577.94K | — | $27.44M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 577.94K | — | $27.44M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | JPMorgan Chase ✦ | 577.94K | — | $27.44M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | JPMorgan Chase ✦ | 577.94K | — | $27.44M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | JPMorgan Chase ✦ | 577.94K | — | $27.44M | 0.0% | n/c | 1 | SEC ↗ |
| 50 | JPMorgan Chase ✦ | 577.94K | — | $27.44M | 0.0% | n/c | 1 | SEC ↗ |
| 51 | JPMorgan Chase ✦ | 577.94K | — | $27.44M | 0.0% | n/c | 1 | SEC ↗ |
| 52 | JPMorgan Chase ✦ | 577.94K | — | $27.44M | 0.0% | n/c | 1 | SEC ↗ |
| 53 | JPMorgan Chase ✦ | 577.94K | — | $27.44M | 0.0% | n/c | 1 | SEC ↗ |
| 54 | JPMorgan Chase ✦ | 577.94K | — | $27.44M | 0.0% | n/c | 1 | SEC ↗ |
| 55 | JPMorgan Chase ✦ | 577.94K | — | $27.44M | 0.0% | n/c | 1 | SEC ↗ |
| 56 | JPMorgan Chase ✦ | 577.94K | — | $27.44M | 0.0% | n/c | 1 | SEC ↗ |
| 57 | JPMorgan Chase ✦ | 577.94K | — | $27.44M | 0.0% | n/c | 1 | SEC ↗ |
| 58 | Morgan Stanley ✦ | 339.92K | — | $16.14M | 0.0% | n/c | 1 | SEC ↗ |
| 59 | Morgan Stanley ✦ | 339.92K | — | $16.14M | 0.0% | n/c | 1 | SEC ↗ |
| 60 | Morgan Stanley ✦ | 339.92K | — | $16.14M | 0.0% | n/c | 1 | SEC ↗ |
| 61 | Morgan Stanley ✦ | 339.92K | — | $16.14M | 0.0% | n/c | 1 | SEC ↗ |
| 62 | Morgan Stanley ✦ | 339.92K | — | $16.14M | 0.0% | n/c | 1 | SEC ↗ |
| 63 | Morgan Stanley ✦ | 339.92K | — | $16.14M | 0.0% | n/c | 1 | SEC ↗ |
| 64 | Morgan Stanley ✦ | 339.92K | — | $16.14M | 0.0% | n/c | 1 | SEC ↗ |
| 65 | Morgan Stanley ✦ | 339.92K | — | $16.14M | 0.0% | n/c | 1 | SEC ↗ |
| 66 | Renaissance Technologies ✦ | 118.10K | +321.8% | $5.61M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 67 | AQR Capital Management ✦ | 65.97K | +95.5% | $3.13M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 68 | AQR Capital Management ✦ | 65.97K | +95.5% | $3.13M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 69 | AQR Capital Management ✦ | 65.97K | +95.5% | $3.13M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 70 | AQR Capital Management ✦ | 65.97K | +95.5% | $3.13M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 71 | Millennium Management ✦ | 20.20K | -93.6% | $958,954 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 72 | D. E. Shaw & Co. ✦ | 17.57K | -67.4% | $834,319 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 73 | Bridgewater Associates ✦ | 4.26K | 신규 | $202,075 | 0.0% | New | 1 | SEC ↗ |
"해당 운용사 비중" = 해당 운용사의 신고된 13F 주식 가치 대비 포지션 비중 — 확신도 지표. ✦ = 선별 운용사.
신규 매수자
| Bridgewater Associates | $202,075 | 0.0% |
청산됨
| Adage Capital Partners | $15.74M | 이었음 0.0% |
공동 보유 빈도 높음
이 증권의 추적 보유자들이 가장 많이 함께 보유하는 종목 — 기본적 관계가 아닌 공동 보유 건수 기준.
출처: 파싱된 13F 보통주 포지션 기반 보유 현황(추적 유니버스, 변동 비교 세트); 내부자 행은 Form 3/4/5에서; 지분은 Schedule 13D/13G에서 수집; 모든 공시는 SEC EDGAR 원문으로 연결됩니다.
보고 기간: Q3 2025 ·
방법론 ·
API를 통해 조회